Suppr超能文献

富含血小板血浆疗法治疗跟腱和髌腱病变:糖尿病患者的疗效(一项回顾性病例对照研究)

Platelet Rich Plasma Therapy in Achilles and Patellar Tendinopathies: Outcomes in Subjects with Diabetes (A Retrospective Case-Control Study).

作者信息

Abate Michele, Paganelli Roberto, Pellegrino Raffaello, Di Iorio Angelo, Salini Vincenzo

机构信息

IRCSS Ospedale San Raffaele, 20132 Milan, Italy.

Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy.

出版信息

J Clin Med. 2024 Sep 13;13(18):5443. doi: 10.3390/jcm13185443.

Abstract

Diabetes mellitus (DM) is associated with a high risk of chronic degenerative Achilles (AT) and Patellar (PT) tendinopathies and ruptures. Growth factors (GFs) synthesis in diabetics is substantially decreased in human connective tissues, including in tendons. Platelet Rich Plasma (PRP), which is enriched in GFs, might prove of great help in tendon healing. The aim of the study was to assess whether pre-existent DM or Impaired Glucose Tolerance (IGT) could influence the clinical outcome in subjects undergoing PRP treatment. Sixty subjects with diabetes/pre-diabetes and sixty euglycemic controls, matched for sex and age, were enrolled. Patients suffering from proximal insertional PT and mid-portion AT, treated with PRP therapy, were included in the study. To assess the basal status and the efficacy of the therapy after 3 and 6 months, the Victorian Institute of Sport Assessment (VISA) questionnaire and the Ultrasound methodology study were used. Patient satisfaction was assessed by means of the Likert Scale. In the population study at 6 months, the mean VISA-score increased (8.92 ± 0.67; -value < 0.001). The improvement in the diabetic group was less evident compared to the controls (-2.76 ± 0.95; -value = 0.003). Even though the improvement was poor, it was still significant. MCID analysis revealed that diabetics had higher risk of therapeutic unsuccess. Logistic regression analysis was applied to assess factors associated with unsatisfactory results (Likert-scale) of PRP treatment: AT (O.R.: 3.05; 95%CI: 1.40-6.64; -value = 0.005), higher BMI values (O.R.: 1.02; 95%CI: 1.01-1.04; -value = 0.01), and lower VISA score values at baseline (O.R.: 0.95; 95%CI: 0.90-0.99; -value = 0.04). PRP treatment in AT and PT chronic tendinopathies resulted in less favorable results in subjects with diabetes compared with euglycemic subjects. Moreover, the subjects with PT showed better results than those with AT.

摘要

糖尿病(DM)与慢性退行性跟腱(AT)和髌腱(PT)病变及断裂的高风险相关。在包括肌腱在内的人体结缔组织中,糖尿病患者的生长因子(GFs)合成显著减少。富含生长因子的富血小板血浆(PRP)可能对肌腱愈合有很大帮助。本研究的目的是评估既往存在的糖尿病或糖耐量受损(IGT)是否会影响接受PRP治疗的患者的临床结局。招募了60名糖尿病/糖尿病前期患者和60名血糖正常的对照者,他们在性别和年龄上相匹配。接受PRP治疗的近端插入性PT和中段AT患者被纳入研究。为了评估基线状态以及治疗3个月和6个月后的疗效,使用了维多利亚运动评估(VISA)问卷和超声方法学研究。通过李克特量表评估患者满意度。在6个月的人群研究中,平均VISA评分有所提高(8.92±0.67;P值<0.001)。与对照组相比,糖尿病组的改善不太明显(-2.76±0.95;P值=0.003)。尽管改善程度不佳,但仍具有显著性。最小临床重要差异(MCID)分析显示,糖尿病患者治疗失败的风险更高。应用逻辑回归分析来评估与PRP治疗结果不满意(李克特量表)相关的因素:跟腱病变(比值比:3.05;95%置信区间:1.40-6.64;P值=0.005)、较高的体重指数值(比值比:1.02;95%置信区间:1.01-1.04;P值=0.01)以及基线时较低的VISA评分值(比值比:0.95;95%置信区间:0.90-0.99;P值=0.04)。与血糖正常的受试者相比,PRP治疗AT和PT慢性肌腱病变在糖尿病患者中产生的效果较差。此外,PT患者的结果比AT患者更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084e/11432448/251224e7846f/jcm-13-05443-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验